IRIS
CIABATTINI, ANNALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.917
EU - Europa 2.728
AS - Asia 410
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 6.065
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.912
IE - Irlanda 624
GB - Regno Unito 614
IT - Italia 551
SE - Svezia 302
CN - Cina 288
UA - Ucraina 207
FR - Francia 140
DE - Germania 116
FI - Finlandia 90
VN - Vietnam 69
ES - Italia 22
IN - India 21
BE - Belgio 18
PL - Polonia 13
IR - Iran 8
GR - Grecia 6
CH - Svizzera 5
NL - Olanda 5
CA - Canada 4
IQ - Iraq 4
JP - Giappone 3
TH - Thailandia 3
TR - Turchia 3
BO - Bolivia 2
BR - Brasile 2
EU - Europa 2
HK - Hong Kong 2
MY - Malesia 2
NO - Norvegia 2
PT - Portogallo 2
RO - Romania 2
SG - Singapore 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
ID - Indonesia 1
LU - Lussemburgo 1
MK - Macedonia 1
MT - Malta 1
MX - Messico 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 6.065
Salva come PNG Salva come JPEG
Città #
Dublin 622
Southend 540
Fairfield 477
Chandler 332
Ashburn 287
Woodbridge 216
Siena 206
Jacksonville 172
Ann Arbor 160
Seattle 157
Cambridge 153
Houston 140
Wilmington 138
Princeton 95
Beijing 85
Dong Ket 68
New York 64
Nanjing 58
Helsinki 55
Florence 39
San Mateo 31
Rome 26
Shanghai 26
San Diego 24
Menlo Park 22
Boardman 21
Shenyang 21
Brussels 18
Lancaster 16
Málaga 16
Nanchang 15
Dearborn 14
Milan 13
Washington 13
Fremont 12
Hebei 12
London 12
Redwood City 11
Kunming 10
San Francisco 9
Tianjin 9
Jiaxing 8
Norwalk 7
Bacoli 6
Changsha 6
Phoenix 6
Baronissi 5
Düsseldorf 5
Jinan 5
Naples 5
Poggibonsi 5
Redmond 5
Saint Louis 5
Venezia 5
Baghdad 4
Kilburn 4
Lanciano 4
Napoli 4
Padova 4
Roccagorga 4
Taizhou 4
Triggiano 4
Zanjan 4
Atlanta 3
Bangalore 3
Gdynia 3
Guangzhou 3
Hangzhou 3
Hounslow 3
Hyderabad 3
Lappeenranta 3
Monteriggioni 3
Nuremberg 3
Salerno 3
Tokyo 3
Toronto 3
Trevi 3
Zhengzhou 3
Aachen 2
Amsterdam 2
Bologna 2
Bonn 2
Brea 2
Cagliari 2
Central 2
Changchun 2
Delhi 2
Foggia 2
Frankfurt am Main 2
Giugliano In Campania 2
Hefei 2
Islington 2
Izmir 2
Lanzhou 2
Lisbon 2
Marano 2
Mascalucia 2
Messina 2
Mestre 2
Minneapolis 2
Totale 4.613
Salva come PNG Salva come JPEG
Nome #
Vaginal immunization to elicit primary T-cell activation and dissemination. 225
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 218
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation 218
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 188
Modulation of Primary Immune Response by Different Vaccine Adjuvants. 182
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice. 172
Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes 158
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 157
Ebola vaccine R&D: Filling the knowledge gaps 155
Role of the microbiota in the modulation of vaccine immune responses 150
Transcriptomics of the vaccine immune response: Priming with adjuvant modulates recall innate responses after boosting 146
Bacillus spores for vaccine delivery. 144
Vaccination in the elderly: The challenge of immune changes with aging 144
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies 141
Adoptive transfer of transgenic T cells to study mucosal adjuvants. 130
Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4(+) and CD8(+) T cells in the genital and intestinal tracts. 128
Immunization with the conjugate vaccine Vi-CRM(197) against Salmonella Typhi induces Vi-specific mucosal and systemic immune responses in mice 128
In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii 127
High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot 126
Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response 124
Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge 124
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. 122
Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii 117
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice 117
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 115
Oral priming of mice by recombinant spores of Bacillus subtilis. 112
Surface display of recombinant proteins on Bacillus subtilis spores 112
Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria 111
null 102
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 92
In vivo primary activation of CD4+ and CD8+ T-cells following mucosal vaccination 86
CTA1-DD has an Adjuvant Effect Once Expressed on the Surface of the Gram-Positive Bacterium Streptococcus gordonii 85
Nasal and vaginal routes of immunization for CD4+ and CD8+ T-cell priming 79
Expression of immunomodulating molecules on the surface of the vaccine vector Streptococcus gordonii 79
Induzione primaria di linfociti T CD4 nel tessuto linfoide associato al naso (NALT) in seguito ad immunizzazione con Streptococcus gordonii 78
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies 77
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population 77
Antibody response and protection from challenge in mice immunized with recombinant Streptococcus gordonii expressing fragment C of tetanus toxin 76
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 76
From bivariate to multivariate analysis of cytometric data: Overview of computational methods and their application in vaccination studies 75
CD4+ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines 74
Primary T-cell response to mucosal vaccination 74
Long-term anti-bacterial immunity against systemic infection by Salmonella enterica serovar typhimurium elicited by a GMMA-based vaccine 72
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 72
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 68
Recombinant gram-positive bacteria for intranasal immunization: characterization of the murine nasal-associated lymphoid tissue and study of local T-cell priming 66
Oral priming of mice using recombinant spores of Bacillus subtilis 65
Primary activation of CD4+ and CD8+ T cells following mucosal vaccination with recombinant bacteria 61
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 58
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 57
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 50
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 50
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 41
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study 36
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 34
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein 29
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 28
Using IFN-gamma release assay to confirm tuberculin skin test improves the screening of latent tuberculosis infection in Italian healthcare workers 27
Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2 25
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration 24
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 24
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 21
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 20
Longitudinal profiling of spike-specific antibody and B cell responses following mRNA-1273 SARS-CoV-2 vaccination in hematopoietic cell transplantation recipients 19
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 18
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 10
Totale 6.196
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.569
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019381 0 0 0 0 0 0 0 0 0 113 137 131
2019/20201.120 123 31 64 181 73 91 105 137 89 120 40 66
2020/20211.066 46 88 33 72 72 98 38 130 90 188 96 115
2021/2022827 64 126 42 59 29 13 44 28 44 79 114 185
2022/20231.210 76 141 171 135 102 218 40 104 87 31 81 24
2023/20241.053 33 34 99 79 54 305 365 43 24 17 0 0
Totale 6.196